Good day. Dona McAfield here and this is the RVC Clinical Podcast. Thank you for listening and thank you for

subscribing on your smartphone or whatever device that you have. We're really grateful for you to take the time to download and listen to this obviously podcast. We don't ask for anything really in return. But actually, well, there is one thing. If you could just pop to the Apple Podcast Store or iTunes and leave us a review. So a five-star review would be great. We've had a couple sort of recently and that's great and it works on metrics that will push us up on the tree of veterinary clinical podcast information so that if someone sort of types in veterinary that at least we come up there and enable people who

might be like you wanting to find out a bit more of this type of information or this type of

podcast. So please sort of keep it up. I can't sort of lay with that point more. So that would

be great if you just take a couple of minutes over your day and give us a review.

So today this is number three of the Stein sessions, trademark, and I was talking to Dr. Stein

Neeson, who's one of our internal medics here at the RVC and has been here for, it's probably

an institution, I'm sure one day he'll have a statue or at least portrait in the hall as you as you enter and say thank you Stein for for

returning yet again you're welcome it's a pleasure and I thought I thought today

because you're interesting in in what's gonna happen tomorrow you, what's the next sort of best thing and definitely

like toys, even though the podcasts have been around for a lot longer than both of us have been

at the RVC, it seems to be like a good way to distribute sort of information. But what is the

future for diabetic treatment in dogs and cats?

So I suppose the first question I have would be probably like the oral hypoglycemic agents.

Do you think are they more of a gimmick or is this something that you think has some traction for the future?

Yeah, I mean, I think there will always be an attraction to replace injections with oral drugs,

you know, and that's true in human medicine with human diabetics, but maybe even more so

with animals and pets, because again, you don't get your pet because you want to stab it with an

needle you know it's very yeah different from what you intended to do with the pets you wanted to

stroke it and now you do a medical procedure like an injection so there will always be a drive to try to get the current treatment option,

which is dominated by insulin injections, replaced by something like a pill. And that will be

sort of the more immediate future of where diabetes will try to go. And there are some options.

...